pirfenidone viatris
viatris limited - pirfenidonă - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - imunosupresoare - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).
dasatinib viatris 100 mg
synthon hispania, s.l. - spania - dasatinibum - compr. film. - 100mg - inhibitori de protein-kinaza
dasatinib viatris 140 mg
synthon hispania, s.l. - spania - dasatinibum - compr. film. - 140mg - inhibitori de protein-kinaza
dasatinib viatris 20 mg
synthon hispania, s.l. - spania - dasatinibum - compr. film. - 20mg - inhibitori de protein-kinaza
dasatinib viatris 50 mg
synthon hispania, s.l. - spania - dasatinibum - compr. film. - 50mg - inhibitori de protein-kinaza
dasatinib viatris 70 mg
synthon hispania, s.l. - spania - dasatinibum - compr. film. - 70mg - inhibitori de protein-kinaza
dasatinib viatris 80 mg
synthon hispania, s.l. - spania - dasatinibum - compr. film. - 80mg - inhibitori de protein-kinaza
vancomicina viatris 1000 mg
biologici italia laboratories s.r.l. - italia - vancomycinum - pulb. pt. sol. perf. - 1000mg - alte antibacteriene antibacteriene glicopeptidice
vancomicina viatris 500 mg
biologici italia laboratories s.r.l. - italia - vancomycinum - pulb. pt. sol. perf. - 500mg - alte antibacteriene antibacteriene glicopeptidice
dapagliflozin viatris
viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - medicamente utilizate în diabet - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 și 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.